Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
NCT01828762
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
DC-TC+GM-CSF
Sponsor
Shanghai AbelZeta Ltd.
Collaborators
[object Object]
[object Object]